Deep dermal injection of non-absorbable gel polymer for HIV-related facial lipoatrophy
Summary
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on deep dermal injection of non-absorbable gel polymer for HIV-related facial lipoatrophy.
Description
Facial lipoatrophy (facial wasting) is a loss of fat underneath the skin, often on the face. It can occur as a side effect of antiretroviral drug treatment for HIV. Gel polymers are water-based, man-made substances that are injected under the skin to re-contour the depleted areas.
OPCS4.6 Code(s):
S50.4 Injection of inert substance into subcutaneous tissue NEC
Z47.- Skin of face
Includes: Subcutaneous tissue of face
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding
Details
Skin
British Association of Dermatologists
British Association of Plastic Reconstructive and Aesthetic Surgeons
British Association of Plastic Surgeons
British HIV Association
Contact details:
Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA
Links:
This page was last updated: 11 February 2011
